COVID-19 clinical studies in Mexico 2024, by phase
As of April 2024, a total of 78 clinical studies targeting COVID-19 in Mexico were in phase 3. Meanwhile, two COVID-19 clinical trials were in early phase 1 in the North American country. As of June 3, 2022, there were over 1.5 thousand drugs and vaccines in development targeting the coronavirus disease (COVID-19) worldwide.